AC
DGX icon

AlphaCore Capital’s Quest Diagnostics DGX Stock Holding History

AlphaCore Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Buy
9,371
+2,702
+41% +$530K 0.04% 309
2026
Q1 		$1.31M Buy
6,669
+2,072
+45% +$403K 0.03% 323
2025
Q4 		$798K Buy
4,597
+3,157
+219% +$575K 0.02% 472
2025
Q3 		$274K Buy
1,440
+515
+56% +$91.4K 0.01% 613
2025
Q2 		$166K Buy
+925
New +$161K 0.01% 619

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

AlphaCore Capital's DGX Position: Q2 2026 in Review

AlphaCore Capital increased its Quest Diagnostics (DGX) stake by 41% in Q2 2026, buying an estimated $530K and bringing the position to 9,371 shares worth $1.99M. The position accounts for 0.04% of the portfolio, ranked #309.

AlphaCore Capital first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • AlphaCore Capital held 9,371 shares of Quest Diagnostics worth $1.99M as of Q2 2026.
  • AlphaCore Capital bought 2,702 Quest Diagnostics shares in Q2 2026, an estimated $530K.
  • Quest Diagnostics made up 0.04% of AlphaCore Capital's portfolio in Q2 2026, its #309 holding.
  • AlphaCore Capital first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.